ÂÜÀòÂÒÂ×

Jerome B. Zeldis, M.D., Ph.D. has served as a member of our board of directors since September 2012. Dr. Zeldis is currently the Chief Medical Officer and President of Clinical Development at Sorrento Therapeutics, Inc., a clinical-stage public biopharmaceutical company. Until June 2016, Dr. Zeldis served as Chief Executive Officer of Celgene Global Health and the Chief Medical Officer of Celgene Corporation, a public biopharmaceutical company, where he was employed since 1997. He previously served as Celgene’s Senior Vice President of Clinical Research and Medical Affairs. Previously, Dr. Zeldis served as Assistant Professor of Medicine at Harvard Medical School, Associate Professor of Medicine at University of California, Davis, Clinical Associate Professor of Medicine at Cornell Medical School and Professor of Clinical Medicine at the Robert Wood Johnson Medical School. Dr. Zeldis received an A.B. and M.S. from Brown University and an M.Phil., M.D. and Ph.D. in Molecular Biophysics and Biochemistry (immunochemistry) from Yale University. Dr. Zeldis also serves on the board of directors of Soligenix, Inc., a public biopharmaceutical company, Alliqua, Inc., a public biomedical company, MetaStat, Inc., a molecular diagnostic company, and BioSig Technologies, Inc., a development stage medical device company.